BioCentury | Dec 5, 2020
Product Development

Bispecifics spring ahead at this year’s ASH, SITC

...graft-versus-host reactions during stem cell transplant (No. 354). In8bio Inc....
BioCentury | Mar 21, 2020
Product Development

Under duress, biotechs will have to make hard decisions for patients and themselves about which trials to run

...stocked up on our disposables,” said Larry Lam, CSO of γδ T cell therapy company Incysus...
...α-1 antitrypsin Karen Tkach Tuzman, Associate Editor Sofinnova Ventures Sofinnova Partners Synlogic Inc. Genenta Science s.r.l. Forbion Capital Partners Cerevance Inc. Lundbeckfond Emerge Scynexis Inc. Incysus...
BioCentury | Jul 19, 2019
Product Development

Why GammaDelta would do its Takeda build-to-buy all over again

...cells in preclinical development with partners bluebird bio Inc., Scotia Biologics Ltd. and Nipro Corp. Incysus...
...Gadeta B.V., Utrecht, the Netherlands GammaDelta Therapeutics Ltd., London, U.K. Immatics Biotechnologies GmbH, Tuebingen, Germany Incysus...
BioCentury | Jul 20, 2018
Company News

Kite looks to Gadeta for gamma delta T cell tech

...Lymphocyte Activation Technologies S.A., also known as Lymphact (Evora, Portugal); Immatics Biotechnologies GmbH (Tuebingen, Germany); Incysus...
BioCentury | Jul 19, 2018
Company News

Kite, Gadeta in gamma delta T cell deal

...Lymphocyte Activation Technologies S.A., also known as Lymphact (Evora, Portugal); Immatics Biotechnologies GmbH (Tuebingen, Germany); Incysus...
BioCentury | May 25, 2018
Financial News

Lava raises €16M for gamma delta T cell platform

...Lymphocyte Activation Technologies S.A., also known as Lymphact (Evora, Portugal); Immatics Biotechnologies GmbH (Tuebingen, Germany); Incysus...
BioCentury | May 23, 2018
Financial News

Lava raises €16M for gamma delta T cell platform

...Lymphocyte Activation Technologies S.A., also known as Lymphact (Evora, Portugal); Immatics Biotechnologies GmbH (Tuebingen, Germany); Incysus...
BioCentury | May 14, 2018
Company News

Management tracks: Complexa, Immatics

...CMO and EVP. She was CMO and SVP at Adverum Biotechnologies Inc. (NASDAQ:ADVM). Immunotherapy company Incysus...
BioCentury | Jan 18, 2018
Emerging Company Profile

Allogeneic expansion

...their therapeutic use. The company isn’t disclosing a lead indication or clinical timeline. Last week, Incysus...
...Menlo Park, Calif. Gilead Sciences Inc. (NASDAQ:GILD), Foster City, Calif. Immatics Biotechnologies GmbH, Tübingen, Germany Incysus...
...References Martz, L. “Chemo-proof T cells.” BioCentury Innovations (2017) Mark Zipkin, Staff Writer IMA300 IMA301 OmmniCAR Adicet Bio Inc. Immatics Biotechnologies GmbH Incysus...
BioCentury | Dec 8, 2017
Company News

bluebird, TC BioPharm in gamma delta CAR T deal

...Activation Technologies S.A., also known as Lymphact (Evora, Portugal); Immatics Biotechnologies GmbH (Tuebingen, Germany); and Incysus...
...bio Inc. (NASDAQ:BLUE), Cambridge, Mass. Business: Cancer Elizabeth S. Eaton bb2121 bluebird bio Inc. Gadeta B.V. GammaDelta Therapeutics Ltd. Immatics Biotechnologies GmbH Incysus...
Items per page:
1 - 10 of 14
BioCentury | Dec 5, 2020
Product Development

Bispecifics spring ahead at this year’s ASH, SITC

...graft-versus-host reactions during stem cell transplant (No. 354). In8bio Inc....
BioCentury | Mar 21, 2020
Product Development

Under duress, biotechs will have to make hard decisions for patients and themselves about which trials to run

...stocked up on our disposables,” said Larry Lam, CSO of γδ T cell therapy company Incysus...
...α-1 antitrypsin Karen Tkach Tuzman, Associate Editor Sofinnova Ventures Sofinnova Partners Synlogic Inc. Genenta Science s.r.l. Forbion Capital Partners Cerevance Inc. Lundbeckfond Emerge Scynexis Inc. Incysus...
BioCentury | Jul 19, 2019
Product Development

Why GammaDelta would do its Takeda build-to-buy all over again

...cells in preclinical development with partners bluebird bio Inc., Scotia Biologics Ltd. and Nipro Corp. Incysus...
...Gadeta B.V., Utrecht, the Netherlands GammaDelta Therapeutics Ltd., London, U.K. Immatics Biotechnologies GmbH, Tuebingen, Germany Incysus...
BioCentury | Jul 20, 2018
Company News

Kite looks to Gadeta for gamma delta T cell tech

...Lymphocyte Activation Technologies S.A., also known as Lymphact (Evora, Portugal); Immatics Biotechnologies GmbH (Tuebingen, Germany); Incysus...
BioCentury | Jul 19, 2018
Company News

Kite, Gadeta in gamma delta T cell deal

...Lymphocyte Activation Technologies S.A., also known as Lymphact (Evora, Portugal); Immatics Biotechnologies GmbH (Tuebingen, Germany); Incysus...
BioCentury | May 25, 2018
Financial News

Lava raises €16M for gamma delta T cell platform

...Lymphocyte Activation Technologies S.A., also known as Lymphact (Evora, Portugal); Immatics Biotechnologies GmbH (Tuebingen, Germany); Incysus...
BioCentury | May 23, 2018
Financial News

Lava raises €16M for gamma delta T cell platform

...Lymphocyte Activation Technologies S.A., also known as Lymphact (Evora, Portugal); Immatics Biotechnologies GmbH (Tuebingen, Germany); Incysus...
BioCentury | May 14, 2018
Company News

Management tracks: Complexa, Immatics

...CMO and EVP. She was CMO and SVP at Adverum Biotechnologies Inc. (NASDAQ:ADVM). Immunotherapy company Incysus...
BioCentury | Jan 18, 2018
Emerging Company Profile

Allogeneic expansion

...their therapeutic use. The company isn’t disclosing a lead indication or clinical timeline. Last week, Incysus...
...Menlo Park, Calif. Gilead Sciences Inc. (NASDAQ:GILD), Foster City, Calif. Immatics Biotechnologies GmbH, Tübingen, Germany Incysus...
...References Martz, L. “Chemo-proof T cells.” BioCentury Innovations (2017) Mark Zipkin, Staff Writer IMA300 IMA301 OmmniCAR Adicet Bio Inc. Immatics Biotechnologies GmbH Incysus...
BioCentury | Dec 8, 2017
Company News

bluebird, TC BioPharm in gamma delta CAR T deal

...Activation Technologies S.A., also known as Lymphact (Evora, Portugal); Immatics Biotechnologies GmbH (Tuebingen, Germany); and Incysus...
...bio Inc. (NASDAQ:BLUE), Cambridge, Mass. Business: Cancer Elizabeth S. Eaton bb2121 bluebird bio Inc. Gadeta B.V. GammaDelta Therapeutics Ltd. Immatics Biotechnologies GmbH Incysus...
Items per page:
1 - 10 of 14